Related Experiment Video
Updated: May 27, 2026

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion
Xiaolei Liu1, Biyan Duan, Zhaokang Cheng
1The Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, Nankai University, Tianjin 300071, China.
Abstract:
Bone marrow mesenchymal stem cells (MSCs) are considered as a promising cell source to treat the acute myocardial infarction. However, over 90% of the stem cells usually die in the first three days of transplantation. Survival potential, migration ability and paracrine capacity have been considered as the most important three factors for cell transplantation in the ischemic cardiac treatment. We hypothesized that stromal-derived factor-1 (SDF-1)/CXCR4 axis plays a critical role in the regulation of these processes. In this study, apoptosis was induced by exposure of MSCs to H(2)O(2) for 2 h. After re-oxygenation, the SDF-1 pretreated MSCs demonstrated a significant increase in survival and proliferation. SDF-1 pretreatment also enhanced the migration and increased the secretion of pro-survival and angiogenic cytokines including basic fibroblast growth factor and vascular endothelial growth factor. Western blot and RT-PCR demonstrated that SDF-1 pretreatment significantly activated the pro-survival Akt and Erk signaling pathways and up-regulated Bcl-2/Bax ratio. These protective effects were partially inhibited by AMD3100, an antagonist of CXCR4.We conclude that the SDF-1/CXCR4 axis is critical for MSC survival, migration and cytokine secretion.
Insights
Stromal-derived factor-1 (SDF-1) enhances mesenchymal stem cell (MSC) survival and function after transplantation for acute myocardial infarction. The SDF-1/CXCR4 axis is critical for improving MSCs
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Cell Biology
Background:
- Mesenchymal stem cells (MSCs) show promise for treating acute myocardial infarction.
- High MSC mortality post-transplantation limits therapeutic efficacy.
- Key factors for cardiac treatment include survival, migration, and paracrine capacity.
Purpose of the Study:
- To investigate the role of the stromal-derived factor-1 (SDF-1)/CXCR4 axis in regulating MSC survival, migration, and paracrine function.
- To determine if SDF-1 pretreatment can enhance MSC therapeutic potential for ischemic cardiac conditions.
Main Methods:
- Induction of apoptosis in MSCs using H2O2 exposure.
- Pretreatment of MSCs with SDF-1.
- Assessment of MSC survival, proliferation, migration, and cytokine secretion.
- Analysis of signaling pathways (Akt, Erk) and protein expression (Bcl-2/Bax ratio) via Western blot and RT-PCR.
- Inhibition studies using AMD3100, a CXCR4 antagonist.
Main Results:
- SDF-1 pretreatment significantly increased MSC survival and proliferation post-apoptosis induction.
- Enhanced MSC migration and increased secretion of pro-survival and angiogenic factors (bFGF, VEGF) were observed.
- SDF-1 activated pro-survival Akt and Erk pathways and upregulated the Bcl-2/Bax ratio.
- The CXCR4 antagonist AMD3100 partially inhibited these protective effects.
Conclusions:
- The SDF-1/CXCR4 axis plays a critical role in promoting MSC survival, migration, and cytokine secretion.
- SDF-1 pretreatment enhances MSC resilience and therapeutic potential for cardiac repair.
- Targeting the SDF-1/CXCR4 pathway offers a strategy to improve stem cell therapy for myocardial infarction.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells
Cytoskeletal Coordination in Cell Migration

